Palvella Therapeutics, Inc (PVLA) — Cash Flow-to-Debt Ratio
Palvella Therapeutics, Inc (PVLA) has a Cash Flow-to-Debt Ratio of -0.35x as of March 2026, meaning its operating cash flow of $-10.86 Million could theoretically repay 0% of its total liabilities ($31.45 Million) in one year. See Palvella Therapeutics, Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Palvella Therapeutics, Inc Cash Flow-to-Debt Ratio (2020–2025)
Historical debt coverage capacity for Palvella Therapeutics, Inc across 6 annual periods. Also explore how fast is Palvella Therapeutics, Inc growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Palvella Therapeutics, Inc (2020–2025)
Year-by-year debt coverage analysis for Palvella Therapeutics, Inc. For market capitalisation and broader financial context, see PVLA company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.79x | $-25.01 Million | $31.58 Million | ▼ -87.2% |
| 2024 | -0.42x | $-10.84 Million | $25.63 Million | ▲ +64.7% |
| 2023 | -1.20x | $-13.70 Million | $11.43 Million | ▼ -220.8% |
| 2022 | -0.37x | $-14.84 Million | $39.70 Million | ▼ -401.7% |
| 2021 | -0.07x | $-7.66 Million | $102.81 Million | ▲ +88.0% |
| 2020 | -0.62x | $-45.90 Million | $73.98 Million | — |